A rare urea cycle disorder in a neonate: N-acetylglutamate synthetase deficiency

Creative Commons License

Olgac A., Kasapkara C. S., Kilic M., Derinkuyu B. E., Azapagasi E., Kesici S., ...Daha Fazla

ARCHIVOS ARGENTINOS DE PEDIATRIA, cilt.118, sa.6, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 118 Sayı: 6
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5546/aap.2020.eng.e545
  • Dergi Adı: ARCHIVOS ARGENTINOS DE PEDIATRIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Anahtar Kelimeler: urea cycle disorders, inborn, N-acetylglutamate synthase deficiency, hyperammonemia, SYNTHASE DEFICIENCY
  • Gazi Üniversitesi Adresli: Evet

Özet

Urea cycle disorders (UCD), are genetically inherited diseases that may have a poor outcome due to to profound hyperammonemia. We report the case of a baby girl diagnosed as N-acetylglutamate synthase (NAGS) deficiency. The patient was evaluated due to diminished sucking and hypotonicity. Physical examination showed hepatomegaly. Complete blood count, biochemical values and blood gas analyses were normal, acute phase reactants were negative. Further laboratory analyses showed no ketones in blood and highly elevated ammonia. Metabolic tests were inconclusive. Emergency treatment was initiated immediately and she was discharged on the 15th day of admission. NAGS deficiency was confirmed by DN A-analysis. She is now without any dietary restriction or other medication, except N-carbamylglutamate (NCG). NAGS deficiency is the only UCD which can be specifically and effectively treated by NCG. Early recognition of disease will lead to early treatment that may prohibit devastating effects of hyperammonemia.